A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer
IntroductionThe use of patient-reported outcomes (PROs) has been shown to enhance the accuracy of symptom collection and improve overall survival and quality of life. This is the first study comparing concordance and patient preference for two PRO tools: Patient-Reported Outcomes version of the Comm...
Main Authors: | Thomas Jordan, Thitikorn Nuamek, Isabella Fornacon-Wood, Raffaele Califano, Joanna Coote, Margaret Harris, Hitesh Mistry, Paul Taylor, David Woolf, Corinne Faivre-Finn |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1328871/full |
Similar Items
-
Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
by: Minji K. Lee, et al.
Published: (2020-12-01) -
Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
by: Kristin M. Schroeder, et al.
Published: (2023-06-01) -
Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives
by: Minasian LM, et al.
Published: (2022-12-01) -
A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy
by: Mille Guldager Christiansen, et al.
Published: (2023-07-01) -
Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
by: Maximilian Günther, et al.
Published: (2023-07-01)